The fear

Spend ten minutes in any GLP-1 forum and you'll find the same thread, posted fresh every week: "I'm stopping next month and I'm terrified." Sometimes it's the cost: £150 to £300 a month in the UK, hundreds of dollars in the US, indefinitely, out of your own pocket. Sometimes it's side effects, a supply gap, a pregnancy plan, or just wanting to know who you are without it.

The fear deserves a proper answer, not a pep talk. And unusually for a weight-loss question, we have real data: trials that took people off these drugs and measured, month by month, exactly what happened next.

What the withdrawal trials show

When the STEP 1 semaglutide trial ended and treatment stopped, participants were followed for another year. On average they regained about two-thirds of the weight they had lost, and the cardiometabolic improvements faded alongside (Wilding et al., 2022).

SURMOUNT-4 ran the cleaner experiment with tirzepatide: everyone lost weight for 36 weeks, then half switched to placebo. Over the following year, the placebo group regained around 14% of their body weight while those who continued lost a further 5.5% (Aronne et al., JAMA 2024).

So the honest headline: regain is the default outcome. But two details in the data matter just as much. The averages hide a wide spread; a meaningful minority held most of their loss. And regain was gradual, across months, not a switch that flips the day you stop. Gradual means there is time to respond.

Why regain happens (it isn't willpower)

These medicines quiet appetite signalling while they're in your system, and they leave slowly: half-lives of roughly a week (SmPC) mean several weeks of fade rather than a hard stop. As the drug fades, the appetite it was quieting comes back, and it comes back into a body whose biology still defends its old weight. That is physiology, not a character flaw. Nobody white-knuckles their way through a hormone.

Which is exactly why the useful question isn't "will my appetite return?" (yes) but "what structure will be standing when it does?"

Stopping on purpose

• Make it a decision, not a drift. Talk to your prescriber about pace; some people step down doses rather than stopping outright. A planned stop with a review date beats quietly not reordering.
• Keep measuring through the transition. The weeks after your last dose are the worst possible time to stop weighing, and the most common. A weekly trend line is your early-warning system.
• Set your restart trigger in advance. Decide now what number or trend would send you back to your prescriber. Deciding while panicking at a +4kg reading is how stop-start cycles get chaotic.
• Protect the habits the drug made easy. Protein-forward meals, the walking, the logging. The medicine lowered the effort those took; the effort is about to return, so shrink the routine to something you can hold rather than abandoning it whole.

What to watch after your last dose

Weeks one and two usually feel deceptively normal while the drug is still fading. Appetite typically rebuilds over the following month, and that's when the trend line tells you what your maintenance actually looks like. Judge nothing by any single week; watch the direction over four to six. If the trend climbs past the line you set, that isn't failure, it's your trigger doing its job.

We've written more on the mechanics in weight regain after stopping and stop-start cycles, and on how long the drug stays in your system in how much Mounjaro is left in my body (the same tirzepatide maths applies to Zepbound in the US).

The questions everyone asks

Will I regain everything?

The averages say most people regain a substantial share within a year. The spread says it isn't destiny, and the people who kept structure regained least.

How fast does it leave?

Half-lives around a week mean a slow fade over several weeks. Your appetite returns on roughly the same schedule.

Can I restart?

Yes, with your prescriber, usually re-titrating from a low dose. A pre-agreed restart trigger makes it a calm decision instead of a rescue.

Healthcount keeps your trend line running whether or not you're dosing, which is precisely when it earns its keep. Track your transition free.